Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase

  • Yang, Jianjun (Department of interventional radiology, Affiliated Hospital of Yan'an University) ;
  • Yuan, Donghong (Department of interventional radiology, Affiliated Hospital of Yan'an University) ;
  • Xing, Tongchao (Department of General Surgery, The Fourth People's Hospital) ;
  • Su, Hongli (Department of Anesthesiology, Yanan University Affiliated Hospital) ;
  • Zhang, Shengjun (Department of General Surgery, Yanan University Affiliated Hospital) ;
  • Wen, Jiansheng (Department of Radiology, Central Hospital of Tongchuan Mining Bureau) ;
  • Bai, Qiqiang (Department of Pharmacy, Yanan University Affiliated Hospital) ;
  • Dang, Dongmei (Department of Pathogenic microbiology, Medical College of Yan'an University)
  • Received : 2015.11.23
  • Accepted : 2016.03.29
  • Published : 2016.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Ginsenoside Rh2 (GRh2) is the main bioactive component in American ginseng, a commonly used herb, and its antitumor activity had been studied in previous studies. PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK), a serine/threonine protein kinase, is highly expressed in HCT116 colorectal cancer cells. Methods: We examined the effect of GRh2 on HCT116 cells ex vivo. Next, we performed in vitro binding assay and in vitro kinase assay to search for the target of GRh2. Furthermore, we elucidated the underlying molecular mechanisms for the antitumor effect of GRh2 ex vivo and in vivo. Results: The results of our in vitro studies indicated that GRh2 can directly bind with PBK/TOPK and GRh2 also can directly inhibit PBK/TOPK activity. Ex vivo studies showed that GRh2 significantly induced cell death in HCT116 colorectal cancer cells. Further mechanistic study demonstrated that these compounds inhibited the phosphorylation levels of the extracellular regulated protein kinases 1/2 (ERK1/2) and (H3) in HCT116 colorectal cancer cells. In vivo studies showed GRh2 inhibited the growth of xenograft tumors of HCT116 cells and inhibited the phosphorylation levels of the extracellular regulated protein kinases 1/2 and histone H3. Conclusion: The results indicate that GRh2 exerts promising antitumor effect that is specific to human HCT116 colorectal cancer cells through inhibiting the activity of PBK/TOPK.

Keywords

References

  1. Abe Y, Matsumoto S, Kito K, Ueda N. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem 2000;275:21525-31. https://doi.org/10.1074/jbc.M909629199
  2. Gaudet S, Branton D, Lue RA. Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl Acad Sci U S A 2000;97:5167-72. https://doi.org/10.1073/pnas.090102397
  3. Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N, Shigemoto K, Gyo K. Characterization of a MAPKK-like protein kinase TOPK. Biochem Biophys Res Commun 2004;325:997-1004. https://doi.org/10.1016/j.bbrc.2004.10.133
  4. Ayllon V, O'Connor R. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 2007;26:3451-61. https://doi.org/10.1038/sj.onc.1210142
  5. Oh SM, Zhu F, Cho YY, Lee KW, Kang BS, Kim HG, Zykova T, Bode AM, Dong Z. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. Cancer Res 2007;67:5186-94. https://doi.org/10.1158/0008-5472.CAN-06-4506
  6. Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ, Heo YS, Boardman L, Limburg P, Lee HJ, Dong Z. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis 2011;32:921-8. https://doi.org/10.1093/carcin/bgr022
  7. Li S, Zhu F, Zykova T, Kim MO, Cho YY, Bode AM, Peng C, Ma W, Carper A, Langfald A, et al. T-LAK cell-originated protein kinase (TOPK) phosphorylation of MKP1 protein prevents solar ultraviolet light-induced inflammation through inhibition of the p38 protein signaling pathway. J Biol Chem 2011;286:29601-9. https://doi.org/10.1074/jbc.M111.225813
  8. Park JH, Nishidate T, Nakamura Y, Katagiri T. Critical roles of T-LAK cell-originated protein kinase in cytokinesis. Cancer Sci 2010;101:403-11. https://doi.org/10.1111/j.1349-7006.2009.01400.x
  9. Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D, Rapoport AP. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis 2001;27:825-9. https://doi.org/10.1006/bcmd.2001.0452
  10. Park JH, Jeong YJ, Won HK, Choi SY, Park JH, Oh SM. Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-${\kappa}B$ activity in leukemia cells. Cell Signal 2014;26:849-56. https://doi.org/10.1016/j.cellsig.2014.01.004
  11. Wei DC, Yeh YC, Hung JJ, Chou TY, Wu YC, Lu PJ, Cheng HC, Hsu YL, Kuo YL, Chen KY, et al. Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma. Cancer Sci 2012;103:731-8. https://doi.org/10.1111/j.1349-7006.2011.02197.x
  12. Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. Cancer Res 2006;66:9186-95. https://doi.org/10.1158/0008-5472.CAN-06-1601
  13. Joel M, Mughal AA, Grieg Z, Murrell W, Palmero S, Mikkelsen B, Fjerdingstad HB, Sandberg CJ, Behnan J, Glover JC, et al. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo. Mol Cancer 2015;14:121. https://doi.org/10.1186/s12943-015-0398-x
  14. Zhu F, Zykova TA, Kang BS, Wang Z, Ebeling MC, Abe Y, Ma WY, Bode AM, Dong Z. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology 2007;133:219-31. https://doi.org/10.1053/j.gastro.2007.04.048
  15. Hu F, Gartenhaus RB, Eichberg D, Liu Z, Fang HB, Rapoport AP. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene 2010;29:5464-74. https://doi.org/10.1038/onc.2010.275
  16. Kim DJ, Li Y, Reddy K, Lee MH, Kim MO, Cho YY, Lee SY, Kim JE, Bode AM, Dong Z. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res 2012;72:3060-8. https://doi.org/10.1158/0008-5472.CAN-11-3851
  17. Matsuo Y, Park JH, Miyamoto T, Yamamoto S, Hisada S, Alachkar H, Nakamura Y. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci Transl Med 2014;259:251-9.
  18. Liu Z, Li Y, Li X, Ruan CC, Wang LJ, Sun GZ. The effects of dynamic changes of malonyl ginsenosides on evaluation and quality control of Panax ginseng C.A. Meyer. J Pharm Biomed Anal 2012;64-65:56-63. https://doi.org/10.1016/j.jpba.2012.02.005
  19. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, Kim HS, Ha J, Kim MS, Kwon DY. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 2007;364:1002-8. https://doi.org/10.1016/j.bbrc.2007.10.125
  20. Jiang Z, Wang Y, Zhang X, Peng T, Lu Y, Leng J, Xie Q. Preventive and therapeutic effects of ginsenoside Rb1 for neural injury during cerebral infarction in rats. Am J Chin Med 2013;41:341-52. https://doi.org/10.1142/S0192415X13500250
  21. Jovanovski E, Bateman EA, Bhardwaj J, Fairgrieve C, Mucalo I, Jenkins AL, Vuksan V. Effect of Rg3-enriched Korean Red Ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial. J Am Soc Hypertens 2014;8:537-41. https://doi.org/10.1016/j.jash.2014.04.004
  22. Oh SJ, Lee S, Choi WY, Lim CJ. Skin anti-photoaging properties of ginsenoside Rh2 epimers in UV-B-irradiated human keratinocyte cells. J Biosci 2014;39:673-82. https://doi.org/10.1007/s12038-014-9460-x
  23. Tang XP, Tang GD, Fang CY, Liang ZH, Zhang LY. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol 2013;19:1582-92. https://doi.org/10.3748/wjg.v19.i10.1582
  24. Chung KS, Cho SH, Shin JS, Kim DH, Choi JH, Choi SY, Rhee YK, Hong HD, Lee KT. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-${\beta}$ expression. Carcinogenesis 2013;34:331-40. https://doi.org/10.1093/carcin/bgs341
  25. Zhang Q, Hong B, Wu S, Niu T. Inhibition of prostatic cancer growth by ginsenoside Rh2. Tumour Biol 2015;36:2377-81. https://doi.org/10.1007/s13277-014-2845-5
  26. Liu S, Chen M, Li P, Wu Y, Chang C, Qiu Y, Cao L, Liu Z, Jia C. Ginsenoside Rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell Physiol Biochem 2015;36:499-508. https://doi.org/10.1159/000430115
  27. Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, Liu Y. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol 2014;35:5593-8. https://doi.org/10.1007/s13277-014-1739-x
  28. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 2004;27:61-7. https://doi.org/10.1007/BF02980048
  29. Zhang C, Yu H, Hou J. Effects of 20(S)-ginsenoside Rh2 and 20(R)-ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells. Zhongguo Zhong Yao Za Zhi 2011;36:1670-4.
  30. Liu J, Shimizu K, Yu H, Zhang C, Jin F, Kondo R. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells. Fitoterapia 2010;81:902-5. https://doi.org/10.1016/j.fitote.2010.05.020
  31. Zheng Y, Nan H, Hao M, Song C, Zhou Y, Gao Y. Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells. Biomed Rep 2013;4:555-8.
  32. Xia X, Jiang B, Liu W, Wang P, Mou Y, Liu Y, Zhao Y, Bi X. Anti-tumor activity of three novel derivatives of ginsenoside on colorectal cancer cells. Steroids 2014;80:24-9. https://doi.org/10.1016/j.steroids.2013.11.018
  33. Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for? J Cell Sci 2003;116:3677-85. https://doi.org/10.1242/jcs.00735
  34. Wargovich MJ. Colon cancer chemoprevention with ginseng and other botanicals. J Korean Med Sci 2001;16:S81-6. https://doi.org/10.3346/jkms.2001.16.S.S81
  35. Cui X, Jin Y, Poudyal D, Chumanevich AA, Davis T, Windust A, Hofseth A, Wu W, Habiger J, Pena E, et al. Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis. Carcinogenesis 2010;31:1734-41. https://doi.org/10.1093/carcin/bgq163
  36. Li B, Wang CZ, He TC, Yuan CS, Du W. Antioxidants potentiate American ginseng-induced killing of colorectal cancer cells. Cancer Lett 2010;289:62-70. https://doi.org/10.1016/j.canlet.2009.08.002
  37. Wang CZ, Zhang Z, Anderson S, Yuan CS. Natural products and chemotherapeutic agents on cancer: prevention vs. treatment. Am J Chin Med 2014;42:1555-8. https://doi.org/10.1142/S0192415X1420002X
  38. Yuan HD, Quan HY, Zhang Y, Kim SH, Chung SH. 20(S)-Ginsenoside Rg3-induced apoptosis in HT-29 colon cancer cells is associated with AMPK signaling pathway. Mol Med Rep 2010;3:825-31.
  39. Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park JH. Proteome changes related to the anti-cancer activity of HT29 cells by the treatment of ginsenoside Rd. Pharmazie 2009;64:242-7.
  40. King ML, Murphy LL. Role of cyclin inhibitor protein p21 in the inhibition of HCT116 human colon cancer cell proliferation by American ginseng (Panax quinquefolius) and its constituents. Phytomedicine 2010;17:261-8. https://doi.org/10.1016/j.phymed.2009.06.008
  41. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011;301:185-92. https://doi.org/10.1016/j.canlet.2010.11.015

Cited by

  1. Dissipation and residues of the diamide insecticide chlorantraniliprole in ginseng ecosystems under different cultivation environments vol.189, pp.11, 2016, https://doi.org/10.1007/s10661-017-6241-7
  2. AKT-targeted anti-inflammatory activity of the methanol extract of Chrysanthemum indicum var. albescens vol.201, pp.None, 2016, https://doi.org/10.1016/j.jep.2017.03.001
  3. Ginsenoside 20(S)-Rh2 Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells: Role of Orphan Nuclear Receptor Nur77 vol.65, pp.35, 2017, https://doi.org/10.1021/acs.jafc.7b02299
  4. Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNA-ceRNA interaction network in colorectal cancer vol.53, pp.3, 2016, https://doi.org/10.3892/ijo.2018.4443
  5. A hederagenin saponin isolated from Clematis ganpiniana induces apoptosis in breast cancer cells via the mitochondrial pathway vol.15, pp.2, 2016, https://doi.org/10.3892/ol.2017.7494
  6. 20(S)-Ginsenoside Rh2 Induce the Apoptosis and Autophagy in U937 and K562 Cells vol.10, pp.3, 2016, https://doi.org/10.3390/nu10030328
  7. New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity vol.8, pp.None, 2016, https://doi.org/10.1038/s41598-017-18938-y
  8. Cancer chemoprevention and therapy using chinese herbal medicine vol.20, pp.1, 2016, https://doi.org/10.1186/s12575-017-0066-1
  9. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment vol.14, pp.None, 2016, https://doi.org/10.2147/ijn.s197889
  10. Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer vol.10, pp.1, 2016, https://doi.org/10.7150/jca.28216
  11. Molecular Mechanisms Underlying Cancer Preventive and Therapeutic Potential of Algal Polysaccharides vol.25, pp.11, 2019, https://doi.org/10.2174/1381612825666190425155126
  12. American Ginseng (Panax quinquefolium L.) as a Source of Bioactive Phytochemicals with Pro-Health Properties vol.11, pp.5, 2016, https://doi.org/10.3390/nu11051041
  13. Ginsenoside Rh2 inhibits proliferation but promotes apoptosis and autophagy by down-regulating microRNA-638 in human retinoblastoma cells vol.108, pp.None, 2016, https://doi.org/10.1016/j.yexmp.2019.03.004
  14. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from Panax ginseng vol.67, pp.31, 2016, https://doi.org/10.1021/acs.jafc.9b03159
  15. Secondary analysis of existing microarray data reveals potential gene drivers of cutaneous squamous cell carcinoma vol.234, pp.9, 2016, https://doi.org/10.1002/jcp.28172
  16. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials vol.11, pp.509, 2019, https://doi.org/10.1126/scitranslmed.aaw8412
  17. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine vol.14, pp.None, 2019, https://doi.org/10.1186/s13020-019-0270-9
  18. Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities vol.52, pp.1, 2020, https://doi.org/10.1080/03602532.2020.1714645
  19. Atractylenolide I Induces Apoptosis and Suppresses Glycolysis by Blocking the JAK2/STAT3 Signaling Pathway in Colorectal Cancer Cells vol.11, pp.None, 2016, https://doi.org/10.3389/fphar.2020.00273
  20. Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells vol.11, pp.None, 2016, https://doi.org/10.3389/fphar.2020.00492
  21. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase. vol.177, pp.10, 2016, https://doi.org/10.1111/bph.14981
  22. Ginsenoside Rg3 Promotes Cell Growth Through Activation of mTORC1 vol.9, pp.None, 2016, https://doi.org/10.3389/fcell.2021.730309
  23. Role of Bioactive Constituents of Panax notoginseng in the Modulation of Tumorigenesis: A Potential Review for the Treatment of Cancer vol.12, pp.None, 2016, https://doi.org/10.3389/fphar.2021.738914
  24. PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential vol.13, pp.9, 2021, https://doi.org/10.3390/cancers13092232
  25. Anti-Cancer Effect of Panax Ginseng and Its Metabolites: From Traditional Medicine to Modern Drug Discovery vol.9, pp.8, 2021, https://doi.org/10.3390/pr9081344
  26. 20(S)-Ginsenoside Rh2-induced apoptosis and protective autophagy in cervical cancer cells by inhibiting AMPK/mTOR pathway vol.86, pp.1, 2021, https://doi.org/10.1093/bbb/zbab189